Literature DB >> 30952595

Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7.

Geoffroy P P Gential1, Tim P Hogervorst1, Elena Tondini2, Michel J van de Graaff1, Herman S Overkleeft1, Jeroen D C Codée1, Gijsbert A van der Marel1, Ferry Ossendorp2, Dmitri V Filippov3.   

Abstract

Covalent linking of immunogenic oligopeptides with synthetic Toll-like receptor ligands is a useful approach to develop self-adjuvanting vaccines. In particular, small-molecule based agonists of Toll-like receptor 7 (TLR7) that are derived from 8-oxo-adenine core are potentially promising because these chemically robust TLR7 ligands can be connected to peptide T-cell epitopes via straightforward solid-phase peptide synthesis. In this contribution we present the synthesis of a Boc-protected 9-benzyl-2-alkoxy-8-oxo-adenine building block and its application in the online solid phase synthesis of three peptide conjugates that differ in the position of the TLR7 ligand within the peptide. The conjugates are able to induce dendritic cell maturation and T cell proliferation while the position of the ligand impacts T cell proliferation potency.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  9-Benzyl-2-butoxy-8-oxo-adenine; Dendritic cells; Synthetic peptide conjugates; T cell proliferation; TLR7 agonist

Year:  2019        PMID: 30952595     DOI: 10.1016/j.bmcl.2019.03.048

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control.

Authors:  Elena Tondini; Niels R M Reintjens; Giulia Castello; Tsolere Arakelian; Marjolein Isendoorn; Marcel Camps; Jana Vree; Gijs A van der Marel; Dmitri V Filippov; Jeroen D C Codee; Ferry Ossendorp
Journal:  NPJ Vaccines       Date:  2022-06-23       Impact factor: 9.399

2.  Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope.

Authors:  Tsung-Che Chang; Yoshiyuki Manabe; Keita Ito; Ryuku Yamamoto; Kazuya Kabayama; Shino Ohshima; Yoshie Kametani; Yukari Fujimoto; Chun-Cheng Lin; Koichi Fukase
Journal:  RSC Adv       Date:  2022-06-29       Impact factor: 4.036

3.  Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions.

Authors:  Frank M Speetjens; Marij J P Welters; Marije Slingerland; Mariette I E van Poelgeest; Peggy J de Vos van Steenwijk; Inge Roozen; Sanne Boekestijn; Nikki M Loof; Gijs G Zom; A Rob P M Valentijn; Willem-Jan Krebber; Nico J Meeuwenoord; Catharina A H Janssen; Cornelis J M Melief; Gijs A van der Marel; Dmitri V Filippov; Sjoerd H van der Burg; Hans Gelderblom; Ferry Ossendorp
Journal:  J Immunother Cancer       Date:  2022-10       Impact factor: 12.469

4.  Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli.

Authors:  Michael Chan; Fitzgerald S Lao; Paul J Chu; Jonathan Shpigelman; Shiyin Yao; Jason Nan; Fumi Sato-Kaneko; Vicky Li; Tomoko Hayashi; Maripat Corr; Dennis A Carson; Howard B Cottam; Nikunj M Shukla
Journal:  J Med Chem       Date:  2019-10-25       Impact factor: 7.446

5.  Systematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated Antigen.

Authors:  Rui-Jun Eveline Li; Tim P Hogervorst; Silvia Achilli; Sven C Bruijns; Tim Arnoldus; Corinne Vivès; Chung C Wong; Michel Thépaut; Nico J Meeuwenoord; Hans van den Elst; Herman S Overkleeft; Gijs A van der Marel; Dmitri V Filippov; Sandra J van Vliet; Franck Fieschi; Jeroen D C Codée; Yvette van Kooyk
Journal:  Front Chem       Date:  2019-10-04       Impact factor: 5.221

6.  Immunomodulatory Response of Toll-like Receptor Ligand-Peptide Conjugates in Food Allergy.

Authors:  Jorge Losada Méndez; Francisca Palomares; Francisca Gómez; Pedro Ramírez-López; Javier Ramos-Soriano; Maria Jose Torres; Cristobalina Mayorga; Javier Rojo
Journal:  ACS Chem Biol       Date:  2021-11-11       Impact factor: 5.100

7.  C-Mannosyl Lysine for Solid Phase Assembly of Mannosylated Peptide Conjugate Cancer Vaccines.

Authors:  Tim P Hogervorst; R J Eveline Li; Laura Marino; Sven C M Bruijns; Nico J Meeuwenoord; Dmitri V Filippov; Herman S Overkleeft; Gijsbert A van der Marel; Sandra J van Vliet; Yvette van Kooyk; Jeroen D C Codée
Journal:  ACS Chem Biol       Date:  2020-02-20       Impact factor: 5.100

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.